Literature DB >> 28917280

A Novel Use of the Intraoperative MRI for Metastatic Spine Tumors: Laser Interstitial Thermal Therapy for Percutaneous Treatment of Epidural Metastatic Spine Disease.

Jonathan G Thomas1, Wajd N Al-Holou1, Dhiego Chaves de Almeida Bastos1, Amol J Ghia1, Jing Li1, Andrew J Bishop1, Behrang Amini1, Laurence D Rhines1, Claudio E Tatsui2.   

Abstract

Spinal laser interstitial thermal therapy (LITT) appears to be a promising novel modality for treatment of epidural metastatic spine disease in patients who are poor candidates for larger-scale oncologic spinal surgery and can act synergetically with spinal stereotactic radiosurgery to maximize local control and palliate pain. This technique is ideally suited for the intraoperative MRI suite to monitor the extent of the ablation in the epidural space. As percutaneous navigation, imaging, and LITT technology improve, broader applicability of this minimally invasive technique in spinal oncology is foreseen.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Laser interstitial thermal therapy; Metastatic spine tumors; Spinal stereotactic radiosurgery

Mesh:

Year:  2017        PMID: 28917280     DOI: 10.1016/j.nec.2017.05.006

Source DB:  PubMed          Journal:  Neurosurg Clin N Am        ISSN: 1042-3680            Impact factor:   2.509


  2 in total

1.  MRI-Guided Cryoablation of Epidural Malignancies in the Spinal Canal Resulting in Neural Decompression and Regrowth of Bone.

Authors:  Thomas C Lee; Jeffrey P Guenette; Ziev B Moses; John H Chi
Journal:  AJR Am J Roentgenol       Date:  2018-09-24       Impact factor: 3.959

2.  Multicenter validation of automated trajectories for selective laser amygdalohippocampectomy.

Authors:  Vejay N Vakharia; Rachel E Sparks; Kuo Li; Aidan G O'Keeffe; Fernando Pérez-García; Lucas G S França; Andrew L Ko; Chengyuan Wu; Joshua P Aronson; Brett E Youngerman; Ashwini Sharan; Guy McKhann; Sebastien Ourselin; John S Duncan
Journal:  Epilepsia       Date:  2019-08-07       Impact factor: 5.864

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.